On Monday, Safety Shot Inc SHOT announced its intention to develop its Safety Shot functional beverage platform in a concentrated form to treat alcohol poisoning in hospital and emergency settings.
The Safety Shot beverage, scheduled to launch in Q4 2023, is the first patented beverage that helps people recover faster by reducing blood alcohol content and enhancing clarity.
The Safety Shot platform operates through four Mechanisms of Action, including improving central nervous system activity, cognition, and motor cortex function.
It is designed to quickly decrease blood alcohol levels and prevent residual alcohol in the body from being absorbed through the gut by creating a protective shield around the gut wall.
Safety Shot lowers blood alcohol content by up to 50% in 30 minutes. The company claims that Safety Shot’s patented formula speeds up the conversion of alcohol into sugar in the body.
In 2020, over 52 million people in the U.S. were admitted to hospital emergency departments due to acute alcohol consumption.
There are approximately 20,000 cases of alcohol poisoning each year in the U.S.
According to the U.S. Centers for Disease Control, 2,200 people die from alcohol poisoning each year in the U.S., which amounts to about six deaths per day.
On Friday, Jupiter Wellness Inc. changed its name to Safety Shot Inc. after acquiring Safety Shot. The product is currently being produced at facilities across the U.S. in preparation for its Q4 2023 launch.
Price Action: SHOT shares are down 2.11% at $1.39 on the last check Tuesday.
